Lung neuroendocrine tumors (lung NETs) make up 20-30% of all neuroendocrine cancers, yet their diversity and complexity have long puzzled researchers and clinicians. Now, thanks to cutting-edge research, we’re one step closer to precision medicine that tailors treatments specifically for each patient. At NETRF, we’re excited to share recent findings that highlight a simple yet … Continue reading Unlocking Personalized Treatment for Lung Neuroendocrine Tumors